Vanderbilt Ingram Cancer Center

After undergoing precision radiation therapy at Vanderbilt-Ingram Cancer Center, 90-year-old Imogene Stranch quickly returned to her workout routine at the Bellevue Family YMCA.

A VUMC video telling his story has been viewed tens of thousands of times.

A receptor thought to be a cell growth inhibitor actually sends pro-survival signals in small cell lung cancer and is a candidate biomarker for poor prognosis.

Cancer made itself known to Ashley Larcinese in 2004 for the first time — when she was earning a graduate degree in information technology from Belmont University and was introduced to Nashville entrepreneur Sonny Clark, the mentor who took her under his wing and helped launch her career. He was fighting leukemia at the time.

Sarah Rohde long had an interest in treating cancer, and her research during her undergraduate and medical school years at the University of Virginia underscored that. What she didn’t expect was to become a surgeon.

In the first large-scale analysis of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have shown that heart and vessel complications include myocarditis, pericarditis, vasculitis and arrhythmias, and that they occur early in the course of treatment.

A new grant from the National Cancer Institute (NCI) will fund an intensively mentored training experience for clinical fellows at Vanderbilt University Medical Center for the next five years.